Anxiety and depression are highly prevalent in patients with medical diseases like coronary heart disease, requiring psychopharmacological and psychotherapeutic treatment according to general guidelines.
OBJECTIVES: Anxiety and depression are more prevalent in patients with medical diseases than in the general population. The current diagnostic systems for depression/anxiety in the field of comorbidity, however, are problematic. RESULTS AND CONCLUSIONS: Higher comorbidity has deteriorating consequences in all bio-psycho-social respects. The aetiologic connections between medical disease and psychological disorders are complex bidirectional somato-psycho-somatic ones. Seven modalities of comorbidity for coronary heart disease (myocardial infarction) and depression/anxiety are discussed. The psychopharmacological and psychotherapeutic treatment of anxiety/depression in patients with medical diseases follows general guidelines.
No takes yet. Share an insight, caveat, or question.
Schüßler et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: